logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Loretta J. Nastoupil

The University of Texas MD Anderson Cancer Center
H指数:59
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world use of tafasitamab for relapsed or refractory diffuse large B-cell lymphoma among racial and ethnic minorities in the United States

美国种族和族裔少数群体中复发或难治性弥漫性大B细胞淋巴瘤患者使用tafasitamab的真实世界研究

Oncologist
IF4.2
2026-09-120
OAAI
Narendranath Epperla, MD, MS; Loretta J Nastoupil, MD; Bruce Feinberg, DO; John Galvin, MD, MS, MPH; Prathamesh Pathak, MS; Theresa Amoloja, MPH; Danielle Gentile, PhD; Parisa Asgarisabet, PhD; Kim Saverno, PhD, RPh
Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study

大B细胞淋巴瘤二线治疗的治疗模式与疗效：LEO CReWE研究的结果

Blood Cancer Journal
IF11.6
2026-07-230
OA
Jean L. Koff; Melissa C. Larson; Jonathon B. Cohen; Izidore S. Lossos; Peter Martin; Thomas M. Habermann; Carla Casulo; Samuel Yamshon; Andrea Lo-Rossi; Ashwini Shewade; Connie Lee Batlevi; Anthony Masaquel; Yong Mun; Yucai Wang; Arushi Khurana; Grzegorz S. Nowakowski; Dai Chihara; Eric Mou; Umar Farooq; Dilan Patel; Amy Ayers; Tanner W. Reicks; James R. Cerhan; Christopher R. Flowers; Matthew J. Maurer; Loretta J. Nastoupil
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

2024年国际滤泡性淋巴瘤科学研讨会共识建议

Blood Advances
IF7.1
2025-12-050
OAAI
Reid Merryman; Sarah C. Rutherford; Stephen Ansell; Philippe Armand; John P. Leonard; Loretta Nastoupil; Sonali M. Smith; John Timmerman; Andrew D. Zelenetz; Meghan Gutierrez; Wendy Béguelin; Carla Casulo; James Cerhan; Michael Green; Brad Kahl; Robert Kridel; Brian Link; Matthew J. Maurer; Bertrand Nadel; Andrea J. Radtke
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

基于先前CD19定向CAR T暴露的大B细胞淋巴瘤中Tafasitamab和Lenalidomide的治疗效果

HEMASPHERE
IF14.6
2025-11-180
OAAI
Merrill, Mwanasha H.; Redd, Robert A.; Lambert, Nicholas; Caimi, Paolo F.; Pullarkat, Priyanka; Godby, Richard C.; Bond, David A.; Wehmeyer, Graham T.; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J.; Crombie, Jennifer L.; Abramson, Jeremy S.; Khurana, Arushi; Nowakowski, Grzegorz S.; Maddocks, Kami; Rutherford, Sarah C.; Kahl, Brad; Okwali, Michelle; Buege, Michael J.; Batlevi, Connie L.; Armand, Philippe; Salles, Gilles; Qualls, David A.
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort

自评生成的Charlson合并症指数在淋巴瘤结局流行病学(LEO)队列中的适应性和表现

Hematological Oncology
IF3.9
2025-10-070
PRE
James R. Cerhan; Tereza Sokolova; Elliott J. Cahn; Mazie Tsang; Christopher S. Strouse; Michelle A. T. Hildebrandt; Allison C. Rosenthal; Andrew L. Feldman; David L. Jaye; Peter Martin; Jonathon B. Cohen; Brad S. Kahl; Izidore S. Lossos; Jonathan W. Friedberg; Loretta J. Nastoupil; Brian K. Link; Thomas M. Habermann; Matthew J. Maurer; Carla Casulo; Carrie A. Thompson; Annalynn M. Williams; Christopher R. Flowers
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts

滤泡性淋巴瘤3B亚型具有不同的预后结局：来自前瞻性多中心MER和LEO队列的研究结果

Blood Cancer Journal
IF11.6
2025-08-080
OAAI
Patrizia Mondello; Brianna Negaard; Andrew L. Feldman; Brian K. Link; Carla Casulo; Dai Chihara; David Russler-Germain; Jason Romancik; Caitlin Gribbin; Sara Haddadi; Eric Mou; Ivana N. Micallef; Patrick B. Johnston; Joseph Novak; Yucai Wang; Rebecca L. King; Anne J. Novak; Thomas M. Habermann; Peter Martin; Brad Kahl; Grzegorz S. Nowakowski; Loretta J. Nastoupil; James R. Cerhan; Christopher R. Flowers; Izidore S. Lossos; Richard W. Burack; Matthew J. Maurer; Stephen M. Ansell
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

一项奥滨尤妥珠单抗联合来那度胺治疗既往未治的高肿瘤负荷滤泡性淋巴瘤的II期研究

Blood Advances
IF7.1
2025-06-170
OAAI
Neha Akkad; Lei Feng; Jason R. Westin; Fredrick B. Hagemeister; Hun Ju Lee; Luis Fayad; Sairah Ahmed; Ranjit Nair; Maria Alma Rodriguez; Paolo Strati; Dai Chihara; Christopher R. Flowers; Linda Claret; Karina Ibanez; Michael Wang; Nathan H. Fowler; Jared Henderson; R. Eric Davis; Sattva S. Neelapu; Michael Green; Loretta J. Nastoupil
Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma

lisocabtagene maraleucel和mosunetuzumab治疗第三线或更后线复发或难治性滤泡性淋巴瘤的疗效和安全性匹配调整间接比较

hematology oncology
IF13.5
2025-03-050
OA
Nastoupil, Loretta J.; Bonner, Ashley; Wang, Pearl; Almuallem, Lamees; Desai, Jigar; Farazi, Thalia; Kumar, Jinender; Dahiya, Saurabh
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2025-03-010
PRE
Manzar, Gohar S.; Wu, Susan Y.; Dudzinski, Stephanie O.; Cha, Elaine E.; Yoder, Alison K.; Corrigan, Kelsey L.; Nasr, Lewis F.; Sallard, Gabrielle; Ahmed, Sairah; Fayad, Luis E.; Chihara, Dai; Nair, Ranjit; Westin, Jason R.; Daher, May; Neelapu, Sattva S.; Nastoupil, Loretta J.; Gunther, Jillian R.; Pinnix, Chelsea C.; Dabaja, Bouthaina S.; Strati, Paolo; Fang, Penny Q.
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study

R-gemox治疗复发或难治性弥漫性大b细胞淋巴瘤的疗效: 一项多中心队列研究

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2025-02-070
PRE
Yamshon, S; Koff, JL; Larson, MC; Kahl, BS; Casulo, C; Lossos, IS; Haddadi, S; Stanchina, M; Chihara, D; Ayers, A; Habermann, TM; Wang, YC; Khurana, A; Nowakowski, GS; Reicks, TW; Farooq, U; Link, BK; Cohen, JB; Martin, P; Li, J; Shewade, A; Batlevi, CL; Lo-Rossi, A; Fox, D; Masaquel, A; Mun, Y; Cerhan, JR; Flowers, CR; Maurer, MJ; Nastoupil, LJ
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
FRONTIERS IN IMMUNOLOGY
IF5.9
2025-01-310
OAAI
Manzar, Gohar S.; Pinnix, Chelsea C.; Dudzinski, Stephanie O.; Marqueen, Kathryn E.; Cha, Elaine E.; Nasr, Lewis F.; Yoder, Alison K.; Rooney, Michael K.; Strati, Paolo; Ahmed, Sairah; Nze, Chijioke; Nair, Ranjit; Fayad, Luis E.; Wang, Michael; Nastoupil, Loretta J.; Westin, Jason R.; Flowers, Christopher R.; Neelapu, Sattva S.; Gunther, Jillian R.; Dabaja, Bouthaina S.; Wu, Susan Y.; Fang, Penny Q.
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma

与新生侵袭性大b细胞淋巴瘤相比，CD19 CAR T在转化的惰性淋巴瘤中的结果

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-12-230
OAAI
Thiruvengadam, Swetha Kambhampati; Merryman, Reid; Wang, Yan; Gaulin, Charles; Bezerra, Evandro; Voorhees, Timothy; Seshadri, Madhav R.; Falade, Ayo; Habib, Alma; Ayers, Amy A.; Bailey, Megumi; Brown, Annette; Bailey, Neil; Patel, Krish; Andreadis, Charalambos B.; Kittai, Adam S.; Jacobson, Caron; Palmer, Joycelynne; Forman, Stephen J.; Nastoupil, Loretta; Budde, Lihua E.
Vitamin D in patients with low tumor-burden indolent non- Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
ECLINICALMEDICINE
IF10
2024-12-011
OAAI
Friedberg, Jonathan W.; Brady, Michael T.; Strawderman, Myla; Kahl, Brad S.; Lossos, Izidore S.; Cohen, Jonathon B.; Reagan, Patrick M.; Casulo, Carla; Averill, Barbara L.; Baran, Andrea; Sutamtewagul, Grerk; Barr, Paul M.; Leonard, John P.; Ashton, John M.; Strang, John G.; Vega, Francisco; Peterson, Derick R.; Nastoupil, Loretta J.
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers
HAEMATOLOGICA
IF7.9
2024-11-141
OAAI
Zelikson, Viktoriya; Gurumurthi, Ashwath; Sawalha, Yazeed; Annunzio, Kaitlin; Saha, Aditi; Dong, Ning; Qualls, David; Amoozgar, Behzad; Kahl, Brad; Baird, John; Challa, Pavan; Huntington, Scott F.; Santos, Jennifer; Bair, Steven; Narkhede, Mayur; Li, Shuning; Frosch, Zachary; Ho, Carrie; Smith, Stephen D.; Winter, Allison; Landsburg, Daniel; Furqan, Fateeha; Hamadani, Mehdi; Baird, Katelin; Romancik, Jason; Alharthy, Hanan; Law, Jennie; Bojanini, Leyla; Advani, Ranjana; Hu, Boyu; Johnson, Patrick Connor; Grover, Natalie S.; Merril, Mwanasha; Crombie, Jennifer L.; Shafagati, Nazila; Sterling, Cole; Nastoupil, Loretta J.; Epperla, Narendranath; Ayers, Emily C.
Understanding the Patient Perspective on Treatment Preferences for Follicular Lymphoma

理解患者对滤泡性淋巴瘤治疗偏好的视角

BLOOD
IF23.1
2024-11-050
PRE
Tsang, Mazie; Durani, Urshila; Day, Jonathan R.; Larson, Melissa C.; Holets, Matthew; Yost, Kathleen J.; Cohen, Jonathon B.; Friedberg, Jonathan W.; Lossos, Izidore S.; Martin, Peter; Kahl, Brad S.; Habermann, Thomas M.; Nastoupil, Loretta; Cerhan, James R.; Flowers, Christopher R.; Link, Brian K.; Casulo, Carla; Maurer, Matthew J.

研究方向

暂未获取到该数据
S
Sattva S. Neelapu
H 指数:83论文数:871被引数:4.2万
J
Jason R. Westin
H 指数:57论文数:662被引数:2.9万
C
Christopher R. Flowers
H 指数:84论文数:1,169被引数:3.7万
L
Luis Fayad
H 指数:74论文数:646被引数:2.0万
N
Nathan Fowler
H 指数:62论文数:580被引数:1.8万
S
Sairah Ahmed
H 指数:46论文数:663被引数:8,740
C
Chelsea C. Pinnix
H 指数:43论文数:381被引数:5,832
P
Paolo Strati
H 指数:42论文数:346被引数:6,400
H
Hun Ju Lee
H 指数:40论文数:287被引数:5,995
R
Ranjit Nair
H 指数:25论文数:329被引数:2,950